Department of Surgical Sciences, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
PLoS One. 2012;7(7):e41926. doi: 10.1371/journal.pone.0041926. Epub 2012 Jul 27.
Aldosterone producing lesions are a common cause of hypertension, but genetic alterations for tumorigenesis have been unclear. Recently, either of two recurrent somatic missense mutations (G151R or L168R) was found in the potassium channel KCNJ5 gene in aldosterone producing adenomas. These mutations alter the channel selectivity filter and result in Na(+) conductance and cell depolarization, stimulating aldosterone production and cell proliferation. Because a similar mutation occurs in a mendelian form of primary aldosteronism, these mutations appear to be sufficient for cell proliferation and aldosterone production. The prevalence and spectrum of KCNJ5 mutations in different entities of adrenocortical lesions remain to be defined.
The coding region and flanking intronic segments of KCNJ5 were subjected to Sanger DNA sequencing in 351 aldosterone producing lesions, from patients with primary aldosteronism and 130 other adrenocortical lesions. The specimens had been collected from 10 different worldwide referral centers.
G151R or L168R somatic mutations were identified in 47% of aldosterone producing adenomas, each with similar frequency. A previously unreported somatic mutation near the selectivity filter, E145Q, was observed twice. Somatic G151R or L168R mutations were also found in 40% of aldosterone producing adenomas associated with marked hyperplasia, but not in specimens with merely unilateral hyperplasia. Mutations were absent in 130 non-aldosterone secreting lesions. KCNJ5 mutations were overrepresented in aldosterone producing adenomas from female compared to male patients (63 vs. 24%). Males with KCNJ5 mutations were significantly younger than those without (45 vs. 54, respectively; p<0.005) and their APAs with KCNJ5 mutations were larger than those without (27.1 mm vs. 17.1 mm; p<0.005).
Either of two somatic KCNJ5 mutations are highly prevalent and specific for aldosterone producing lesions. These findings provide new insight into the pathogenesis of primary aldosteronism.
醛固酮产生病变是高血压的常见原因,但肿瘤发生的遗传改变尚不清楚。最近,在醛固酮产生腺瘤的钾通道 KCNJ5 基因中发现了两种复发性体细胞错义突变(G151R 或 L168R)。这些突变改变了通道选择性过滤器,导致 Na+电导和细胞去极化,刺激醛固酮的产生和细胞增殖。由于类似的突变以常染色体显性遗传的形式发生在原发性醛固酮增多症中,这些突变似乎足以引起细胞增殖和醛固酮的产生。KCNJ5 突变在不同肾上腺皮质病变实体中的患病率和谱仍然有待确定。
对来自原发性醛固酮增多症和 130 例其他肾上腺皮质病变患者的 351 个醛固酮产生病变的 KCNJ5 编码区和侧翼内含子片段进行了 Sanger DNA 测序。这些标本来自 10 个不同的全球转诊中心。
醛固酮产生腺瘤中发现 G151R 或 L168R 体细胞突变,每种突变的频率相似。在选择性过滤器附近发现了一个以前未报道的体细胞突变 E145Q,观察到两次。在伴有明显增生的醛固酮产生腺瘤中也发现了体细胞 G151R 或 L168R 突变,但在仅有单侧增生的标本中没有发现。在 130 例非分泌醛固酮的病变中未发现突变。与男性患者相比,女性患者的醛固酮产生腺瘤中 KCNJ5 突变的发生率更高(63%对 24%)。携带 KCNJ5 突变的男性患者明显比不携带 KCNJ5 突变的男性患者年轻(分别为 45 岁和 54 岁;p<0.005),并且携带 KCNJ5 突变的 APA 比不携带 KCNJ5 突变的 APA 更大(分别为 27.1mm 和 17.1mm;p<0.005)。
两种体细胞 KCNJ5 突变均高度普遍且特异性地存在于醛固酮产生病变中。这些发现为原发性醛固酮增多症的发病机制提供了新的见解。